Qube Research & Technologies Ltd
- SEC CIK
- 0001729829
- Latest filing
- Aug 14, 2026
HBIO holding history
Harvard Bioscience Inc in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
HBIO overviewAll 13F holders of HBIOFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −1,703−100.0% | Sold outConverted for a 1-for-10 split | Holders |
| Q4 2025 | 17,029 | $11.4K | <0.1% | −20,226−54.3% | Reduced | Holders |
| Q3 2025 | 37,255 | $16.3K | <0.1% | −13,940−27.2% | Reduced | Holders |
| Q2 2025 | 51,195 | $22.7K | <0.1% | +51,195 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −56−100.0% | Sold out | Holders |
| Q2 2024 | 56 | $160 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 56 | $237 | <0.1% | −8−12.5% | Reduced | Holders |
| Q4 2023 | 64 | $342 | <0.1% | −13,019−99.5% | Reduced | Holders |
| Q3 2023 | 13,083 | $56.3K | <0.1% | +13,083 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −31,068−100.0% | Sold out | Holders |
| Q3 2022 | 31,068 | $80.0K | <0.1% | −2,594−7.7% | Reduced | Holders |
| Q2 2022 | 33,662 | $121.0K | <0.1% | +33,662 | New | Holders |